The American Journal of Medicine (AJM) has launched a blog to create a dynamic forum where physicians and other healthcare professionals can discuss the research and applications for clinical practice that have been published in the Journal.
Abbott has announced that Apollo Hospitals has successfully treated a coronary artery disease patient with the company’s revolutionary ABSORB
ERBA Diagnostics Mannheim, GmbH (Erba), a 100 percent subsidiary of Transasia Bio-Medicals Ltd, (Transasia) – India
Scientists have developed the first genetic blood test for predicting the chances that in vitro fertilization (IVF) will lead to a successful pregnancy.
In a ray of hope for millions of leukaemia patients, American scientists have claimed to have developed a technique which multiplies the small number of stem cells in the donor blood, making it much more potent for the treatment of the fatal disease.
A report by the Millennium Research Group says that the abdominal aortic stent graft market in Europe is estimated to reach $300m by 2015.
Researchers from Purdue University Calumet have turned to a simple, automated method of tracking E.coli.
The United Nations health agency launched a new action plan to halt the spread of resistance to artemisinin, the world’s most potent treatment for malaria, warning that the tremendous gains made in recent years against the disease are under threat.
Researchers at Imperial College London have discovered a protein that triggers rheumatoid arthritis.
Researchers from Victoria University have found that cigarettes contain a number of addictive elements within the tar, in addition to the commonly cited nicotine.
The Juvenile Diabetes Research Foundation will team up with Animas Corporation, a subsidiary of Johnson and Johnson, to create an “artificial pancreas,” the diabetes charity has announced.
A study by researchers from the Kimmel Cancer Center at Jefferson says that the “longevity” protein SIRT1 can inhibit the development of a known precursor to prostate cancer. .
A new device can detect severe heart attacks in more patients, leading to better diagnoses and faster treatment, according to new research. The new 80-lead electrocardiogram (ECG/EKG), PRIME ECG, can give physicians a broader reading of the heart muscle than the traditional 12-lead ECG.
